Biotech SF: Vulcan Capital

Showing posts with label Vulcan Capital. Show all posts

Friday, July 27, 2012

Siluria raises $30 million to convert methane to chemicals, fuel

Siluria Technologies has raised another $30 million in venture capital to move toward commercialization of its methane-to-chemicals conversion technology. The company, located in the FibroGen building in San Francisco’s Mission Bay, has raised $63 million since its founding four years ago. Two new investors led the latest round: Russian firm Bright Capital and Vulcan Capital in Seattle.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.